Clinical Trials Logo

Indirect Calorimetry clinical trials

View clinical trials related to Indirect Calorimetry.

Filter by:
  • None
  • Page 1

NCT ID: NCT05008757 Recruiting - Clinical trials for Indirect Calorimetry

Comparison of Indirect Calorimetry by Q-NRG With Deltatrac II

Start date: August 31, 2021
Phase:
Study type: Observational

Comparison of indirect calorimetry by Q-NRG (Cosmed) with Deltatrac II (Datex)

NCT ID: NCT04500483 Recruiting - Critical Illness Clinical Trials

Indirect Calorimetry in Patients at Risk of Malnutrition

Start date: August 15, 2020
Phase:
Study type: Observational

Burn patients treated in an outpatient clinic and ICU survivors are at risk of malnutrition. There are no clear guidelines determining the energy target in those two populations. The aim of this observation study is to measure the resting energy expenditure of those patients, using indirect calorimetry.

NCT ID: NCT04132700 Withdrawn - Clinical trials for Indirect Calorimetry

Longitudinal Evaluation of Energy Expenditure in ICU Patients From Admission to Discharge Using A Novel Indirect Calorimeter: LEEP-Forward Trial

Start date: March 15, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to utilize the new indirect calorimetry Q-NRG device to the measurement of energy expenditure (EE) throughout your intensive care unit (ICU) stay and ultimately address fundamental questions about metabolism and energy requirements for critically ill patients. The study will use a new, investigational calorimeter called the Q-NRG (the study device, supplied by Cosmed, Italy). The word "investigational" means the study drug or device or biologic is still being tested in research studies and is not approved by the U.S. Food and Drug Administration (FDA). A calorimeter is a device that connects to your breathing machine tubing for a short period (about 30 minutes) and helps to determine what nutrition you may need in your current condition. There are FDA approved calorimeters that have been used as the current standard of care. These devices and the new Q-NRG calorimeter measure oxygen consumption and carbon dioxide production (the gas you breathe out when you exhale) and calculate energy expenditure. Unfortunately, previously existing calorimeters are complicated to use, cumbersome and require time for measurements. It is hoped the new calorimeter will be easier and more practical to use and, through the measurements we take, we will have a better understanding of a patient's caloric needs for healing. Muscle mass and quality play a role in determining EE and metabolic needs. Massive loss of muscle mass and quality that occurs in critical illness significantly affects EE and nutritional needs and should be accounted for in clinical nutrition delivery. Imaging (standard of care abdominal CT and MSK ultrasound) will be used to assess muscle mass, and muscle quality (amount of intramuscular adipose content; IMAT).

NCT ID: NCT03622268 Completed - Clinical trials for Indirect Calorimetry

Using Indirect Calorimetry for Liver Transplants Patients

Start date: December 1, 2017
Phase:
Study type: Observational

Although predicted REE calculated using the Penn state 1988 method agreed (ICC 0.61, p=0.00014) with the measured REE, all three predictive equations had a fixed bias and appeared to be inaccurate for predicting REE for liver transplant recipients. Therefore, precise measurements using indirect calorimetry may be helpful when treating critically ill patients to avoid underestimating or overestimating their metabolic needs.